Just a summary of all the news articles that we could source from different places. A good way to make an investment decision is also to look at how actively the company is engaging with news sources to keep them in the news. In this day and age its critical to have a media presence.
Please consider a small donation if you think this website provides you with relevant information
| Date | Title | Source |
|---|---|---|
| 2024-03-08 5:52:13 am | VIRX Stock Earnings: Viracta Therapeutics Misses EPS for Q4 2023 | InvestorPlace |
| 2024-03-07 1:5:0 pm | Viracta Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update | GlobeNewswire |
| 2024-02-29 5:0:0 am | Viracta Therapeutics Announces Completion of Second-Stage Enrollment into the Peripheral T-Cell Lymphoma Cohort of the NAVAL-1 Trial | GlobeNewswire |
| 2024-02-06 1:5:0 pm | Viracta Therapeutics to Present at the Oppenheimer 34th Annual Healthcare Life Sciences Conference | GlobeNewswire |
| 2024-01-04 5:0:0 am | Viracta Therapeutics Provides Clinical Update and Outlook for 2024 | GlobeNewswire |
| 2023-12-12 5:0:0 am | Viracta Therapeutics Announces Orphan Drug Designation Granted by the U.S. FDA to Nana-val for the Treatment of Nasopharyngeal Carcinoma | GlobeNewswire |
Please consider a small donation if you think this website provides you with relevant information